Inside informationEnglish
Press Release: Sanofi’s SAR446268 earns US fast track designation for the treatment of non-congenital myotonic dystrophy type 1
The file is served by the AMF. We do not host a copy.
Document type
- Issuer
- Sanofi
- Filed
- 23/09/2025, 07:00
- Document type
- Inside information
- AMF sub-type
- Informations privilégiées
- Language
- English
- AMF reference
- 119301_20250923